Certified with Better Business Bureau Beyond Weight Loss: Precision Peptide Therapy
A pilot study subsequently conducted by Holst in collaboration with Mette Zander at Hvidovre Hospital between September 1999 and October 2000 indicated that continuous subcutaneous infusions of synthetic GLP-1 over 6 weeks into patients with quite severe type 2 diabetes dramatically improved their blood sugar control, lowered glycated haemoglobin levels and decreased their body weight
Clinical trials have also reported improvements in glycaemic parameters, including HbA1c, and favourable changes in selected metabolic markers
If you think about high blood pressure, for example, we dont stop medications once the blood pressure is well controlled. Learn more about Wegovy for weight loss
People usually stop taking GLP-1s for weight loss after 1 to 2 years, says Dr
Its especially appealing for people who have been denied coverage elsewhere or are tired of waiting on prior authorizations
